home / stock / cort / cort news


CORT News and Press, Corcept Therapeutics Incorporated

Stock Information

Company Name: Corcept Therapeutics Incorporated
Stock Symbol: CORT
Market: NASDAQ
Website: corcept.com

Menu

CORT CORT Quote CORT Short CORT News CORT Articles CORT Message Board
Get CORT Alerts

News, Short Squeeze, Breakout and More Instantly...

CORT - Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT

Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT PR Newswire LOS ANGELES , Feb. 27, 2026 /PRNewswire/ --  The DJS Law Group reminds investors of a class action lawsuit against Corcept Therape...

CORT - Corcept Therapeutics (NASDAQ: CORT) Investors Who Have Suffered Losses - Contact Kaplan Fox before April 21, 2026 Lead Plaintiff Deadline

NEW YORK, NY - February 26, 2026 ( NEWMEDIAWIRE ) -  Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ: CORT) on behalf of all persons or entities that purc...

CORT - Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT       

The DJS Law Group reminds investors of a class action lawsuit against Corcept Therapeutics Incorporated (“Corcept” or “the Company”) (NASDAQ: CORT ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated th...

CORT - Corcept outlines $900M-$1B 2026 revenue guidance as relacorilant oncology approval nears

2026-02-24 19:48:52 ET More on Corcept Therapeutics Corcept Therapeutics Incorporated (CORT) Q4 2025 Earnings Call Transcript Corcept Therapeutics: The Bad News Is Priced In; The Ovarian Cancer Upside Is Not Why Corcept Therapeutics' Relacorilant Fell Short And What ...

CORT - Corcept Therapeutics Incorporated (CORT) Q4 2025 Earnings Call Transcript

2026-02-24 19:47:53 ET Corcept Therapeutics Incorporated (CORT) Q4 2025 Earnings Call February 24, 2026 5:00 PM EST... Read the full article on Seeking Alpha For further details see: Corcept Therapeutics Incorporated (CORT) Q4 2025 Earnings Call Transcript

CORT - Corcept Therapeutics GAAP EPS of $0.20 misses by $0.07, revenue of $202.1M misses by $52.84M

2026-02-24 16:26:10 ET More on Corcept Therapeutics Corcept Therapeutics: The Bad News Is Priced In; The Ovarian Cancer Upside Is Not Why Corcept Therapeutics' Relacorilant Fell Short And What It Means For The Company Corcept: Korlym Defies Generics As Relacorilant H...

CORT - Corcept Therapeutics Announces Fourth Quarter and Full-Year 2025 Audited Financial Results, Provides Corporate Update

2025 revenue of $761.4 million Full year 2026 revenue guidance of $900 – $1,000 million 2025 net income of $99.7 million Cash and investments of $532.4 million at December 31, 2025 Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage co...

CORT - Kaplan Fox Encourages Investors of Corcept Therapeutics, Inc. (CORT) to Contact the Firm Before Lead Plaintiff Deadline on April 21, 2026

NEW YORK, NY - February 24, 2026 ( NEWMEDIAWIRE ) -  Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ: CORT) on behalf of all persons or entities that purc...

CORT - Kaplan Fox Encourages Corcept Therapeutics, Inc. (CORT) Investors to Inquire About Ongoing Investigation

NEW YORK, NY - February 24, 2026 ( NEWMEDIAWIRE ) -  Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ: CORT). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT T...

CORT - Expected US Company Earnings on Tuesday, February 24th, 2026

Interface Inc. (TILE) is expected to report $0.4 for Q4 2025 Evolent Health Inc Class A (EVH) is expected to report $-0.03 for Q4 2025 MercadoLibre Inc. (MELI) is expected to report $11.77 for Q4 2025 Clean Energy Fuels Corp. (CLNE) is expected to report $-0.1 for Q4 2025 Kiniksa ...

Next 10